argenx to Present at BofA Securities 2024 Health Care Conference
May 07 2024 - 12:00AM
May 7, 2024Amsterdam,
the Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that members of the management team will participate in a fireside
chat at the BofA Securities 2024 Health Care Conference on Tuesday,
May 14, 2024 at 10:00 AM PT in Las Vegas, NV.
A live webcast of the fireside chat may be
accessed on the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately 90 days following the fireside
chat.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx developed and is commercializing
the first approved neonatal Fc receptor (FcRn) blocker in the U.S.,
Japan, Israel, the EU, the UK, Canada and China. The Company is
evaluating efgartigimod in multiple serious autoimmune diseases and
advancing several earlier stage experimental medicines within its
therapeutic franchises. For more information, visit www.argenx.com
and follow us on LinkedIn, X/Twitter, Instagram, Facebook, and
YouTube.
For further information, please
contact:
Media:
Ben Petokbpetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Argen X (EU:ARGX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Argen X (EU:ARGX)
Historical Stock Chart
From Nov 2023 to Nov 2024
